Pluri Inc. (TLV:PLUR)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,094.00
-13.00 (-1.17%)
Dec 4, 2025, 5:24 PM IDT
-42.57%
Market Cap 98.27M
Revenue (ttm) 4.39M
Net Income (ttm) -74.67M
Shares Out n/a
EPS (ttm) -10.34
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 9,149
Average Volume 11,242
Open 1,107.00
Previous Close 1,107.00
Day's Range 1,091.00 - 1,136.00
52-Week Range 1,080.00 - 2,345.00
Beta n/a
RSI 35.01
Earnings Date Nov 13, 2025

About Pluri

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. It develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and immunotherapy platform. The company’s product candidates include PLX-PAD, that is composed of maternal mesenchymal stromal cells originating from the placenta for the treatment of various indications, such as acute muscle in... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 142
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol PLUR
Full Company Profile

Financial Performance

In 2025, Pluri's revenue was $1.34 million, an increase of 309.82% compared to the previous year's $326,000. Losses were -$22.58 million, 8.11% more than in 2024.

Financial numbers in USD Financial Statements

News

There is no news available yet.